BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 32381017)

  • 1. Live-attenuated Salmonella enterica serotype Choleraesuis vaccine with regulated delayed fur mutation confer protection against Streptococcus suis in mice.
    Li YA; Chen Y; Du YZ; Guo W; Chu D; Fan J; Wang X; Bellefleur M; Wang S; Shi H
    BMC Vet Res; 2020 May; 16(1):129. PubMed ID: 32381017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Live attenuated Salmonella enterica serovar Choleraesuis vaccine vector displaying regulated delayed attenuation and regulated delayed antigen synthesis to confer protection against Streptococcus suis in mice.
    Ji Z; Shang J; Li Y; Wang S; Shi H
    Vaccine; 2015 Sep; 33(38):4858-67. PubMed ID: 26238722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salmonella enterica serovar Choleraesuis vector delivering SaoA antigen confers protection against Streptococcus suis serotypes 2 and 7 in mice and pigs.
    Li YA; Ji Z; Wang X; Wang S; Shi H
    Vet Res; 2017 Dec; 48(1):89. PubMed ID: 29268787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Live attenuated Salmonella enterica serovar Choleraesuis vector delivering a conserved surface protein enolase induces high and broad protection against Streptococcus suis serotypes 2, 7, and 9 in mice.
    Li Q; Lv Y; Li YA; Du Y; Guo W; Chu D; Wang X; Wang S; Shi H
    Vaccine; 2020 Oct; 38(44):6904-6913. PubMed ID: 32907758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salmonella enterica serovar Choleraesuis vector delivering a dual-antigen expression cassette provides mouse cross-protection against Streptococcus suis serotypes 2, 7, 9, and 1/2.
    Li YA; Sun Y; Fu Y; Zhang Y; Li Q; Wang S; Shi H
    Vet Res; 2022 Jun; 53(1):46. PubMed ID: 35733156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulated delayed attenuation enhances the immunogenicity and protection provided by recombinant Salmonellaenterica serovar Typhimurium vaccines expressing serovar Choleraesuis O-polysaccharides.
    Zhao X; Liang S; Dai Q; Jia R; Zhu D; Liu M; Wang M; Chen S; Yang Q; Wu Y; Zhang S; Zhang L; Liu Y; Yu Y; Cheng A
    Vaccine; 2018 Aug; 36(33):5010-5019. PubMed ID: 30017143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Characterization of attenuated Salmonella C500 strain with a delta asd mutant and use as an Asd+ balanced-lethal host-vector system].
    Zhao Z; Xu Y; Wu B; Cheng X; Li Y; Tang X; Zhang C; Chen H
    Sheng Wu Gong Cheng Xue Bao; 2009 Jan; 25(1):29-36. PubMed ID: 19441223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subcutaneous vaccination with attenuated Salmonella enterica serovar Choleraesuis C500 expressing recombinant filamentous hemagglutinin and pertactin antigens protects mice against fatal infections with both S. enterica serovar Choleraesuis and Bordetella bronchiseptica.
    Zhao Z; Xue Y; Wu B; Tang X; Hu R; Xu Y; Guo A; Chen H
    Infect Immun; 2008 May; 76(5):2157-63. PubMed ID: 18268026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant-attenuated Salmonella enterica serovar Choleraesuis vector expressing the PlpE protein of Pasteurella multocida protects mice from lethal challenge.
    Zhou G; Tian J; Tian Y; Ma Q; Li Q; Wang S; Shi H
    BMC Vet Res; 2023 Aug; 19(1):128. PubMed ID: 37598169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant attenuated Salmonella Typhimurium with heterologous expression of the Salmonella Choleraesuis O-polysaccharide: high immunogenicity and protection.
    Zhao X; Dai Q; Zhu D; Liu M; Chen S; Sun K; Yang Q; Wu Y; Kong Q; Jia R
    Sci Rep; 2017 Jul; 7(1):7127. PubMed ID: 28754982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salmonella enterica serovar Choleraesuis vector outperforms alum as an adjuvant, increasing a cross-protective immune response against Glaesserella parasuis.
    Li YA; Sun Y; Zhang Y; Wang X; Dieye Y; Wang S; Shi H
    Vet Microbiol; 2023 Dec; 287():109915. PubMed ID: 38000209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Salmonella enterica serovar Typhimurium and Choleraesuis slyA mutant strains for use in live attenuated oral vaccines.
    Haneda T; Okada N; Kikuchi Y; Takagi M; Kurotaki T; Miki T; Arai S; Danbara H
    Comp Immunol Microbiol Infect Dis; 2011 Sep; 34(5):399-409. PubMed ID: 21840053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral Immunization with Attenuated
    Zhou G; Tian Y; Tian J; Ma Q; Huang S; Li Q; Wang S; Shi H
    Microbiol Spectr; 2022 Dec; 10(6):e0236122. PubMed ID: 36377878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulated delayed synthesis of lipopolysaccharide and enterobacterial common antigen of Salmonella Typhimurium enhances immunogenicity and cross-protective efficacy against heterologous Salmonella challenge.
    Huang C; Liu Q; Luo Y; Li P; Liu Q; Kong Q
    Vaccine; 2016 Aug; 34(36):4285-92. PubMed ID: 27423383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deletions in
    Fuche FJ; Jones JA; Ramachandran G; Higginson EE; Simon R; Tennant SM
    Hum Vaccin Immunother; 2019; 15(6):1427-1435. PubMed ID: 29927725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intranasal immunization with a live Streptococcus suis isogenic ofs mutant elicited suilysin-neutralization titers but failed to induce opsonizing antibodies and protection.
    Kock C; Beineke A; Seitz M; Ganter M; Waldmann KH; Valentin-Weigand P; Baums CG
    Vet Immunol Immunopathol; 2009 Dec; 132(2-4):135-45. PubMed ID: 19505730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction, characterization and evaluation of the protective efficacy of the Streptococcus suis double mutant strain ΔSsPep/ΔSsPspC as a live vaccine candidate in mice.
    Hu J; You W; Wang B; Hu X; Tan C; Liu J; Chen H; Bei W
    Microbiol Res; 2015 Jan; 170():87-94. PubMed ID: 25220429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Live Streptococcus suis type 5 strain XS045 provides cross-protection against infection by strains of types 2 and 9.
    Jiang X; Yang Y; Zhu L; Gu Y; Shen H; Shan Y; Li X; Wu J; Fang W
    Vaccine; 2016 Dec; 34(51):6529-6538. PubMed ID: 27349838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salmonella Typhimurium TTSS-2 deficient mig-14 mutant shows attenuation in immunocompromised mice and offers protection against wild-type Salmonella Typhimurium infection.
    Pati NB; Vishwakarma V; Selvaraj SK; Dash S; Saha B; Singh N; Suar M
    BMC Microbiol; 2013 Oct; 13():236. PubMed ID: 24148706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity and protective efficacy of a Salmonella Enteritidis sptP mutant as a live attenuated vaccine candidate.
    Lin Z; Tang P; Jiao Y; Kang X; Li Q; Xu X; Sun J; Pan Z; Jiao X
    BMC Vet Res; 2017 Jun; 13(1):194. PubMed ID: 28646853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.